Medifast, Inc.
MED
$10.53
$0.100.96%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 385.79M | 429.70M | 480.45M | 543.45M | 602.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 385.79M | 429.70M | 480.45M | 543.45M | 602.46M |
| Cost of Revenue | 110.60M | 118.43M | 125.67M | 141.88M | 157.84M |
| Gross Profit | 275.19M | 311.27M | 354.78M | 401.58M | 444.62M |
| SG&A Expenses | 285.20M | 299.97M | 337.29M | 390.90M | 424.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 400.00M | 422.89M | 467.46M | 537.27M | 587.08M |
| Operating Income | -14.21M | 6.80M | 12.99M | 6.18M | 15.38M |
| Income Before Tax | -5.64M | 2.02M | 6.25M | -7.27M | 3.79M |
| Income Tax Expenses | 13.03M | 1.77M | 2.62M | -275.00K | 1.70M |
| Earnings from Continuing Operations | -18.67 | 0.25 | 3.64 | -7.00 | 2.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.67M | 248.00K | 3.64M | -7.00M | 2.09M |
| EBIT | -14.21M | 6.80M | 12.99M | 6.18M | 15.38M |
| EBITDA | 30.00K | 20.76M | 26.69M | 18.91M | 28.09M |
| EPS Basic | -1.70 | 0.02 | 0.33 | -0.64 | 0.19 |
| Normalized Basic EPS | -0.32 | 0.83 | 1.07 | 0.30 | 0.93 |
| EPS Diluted | -1.71 | 0.01 | 0.32 | -0.65 | 0.18 |
| Normalized Diluted EPS | -0.32 | 0.83 | 1.07 | 0.30 | 0.93 |
| Average Basic Shares Outstanding | 43.92M | 43.87M | 43.81M | 43.76M | 43.72M |
| Average Diluted Shares Outstanding | 43.99M | 43.98M | 43.96M | 43.84M | 43.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.04% | 78.63% | 5.39% | -2.84% | 34.18% |